Equal-WT
WhaleScore 2.0
?
Vivo Capital is based out of Palo Alto. Their last reported 13F filing for Q2 2024 included $1,082,541,398 in managed 13F securities
and a top 10 holdings concentration of 76.04%. Vivo Capital's largest holding is Soleno Therapeutics Inc with shares held of 7,316,851. Whalewisdom has at least 37 13F filings, and 3 13D filings
2024-06-30
Top Buys (13F)
Name | % Change |
---|---|
ERAS Erasca Inc | 1.47% |
CELC Celcuity Inc | 0.92% |
ABEOW ABEONA THERAPEUTICS | 0.72% |
CRBP Corbus Pharmaceutica | 0.7% |
TIL Instil Bio Inc | 0.06% |
2024-06-30
Top Sells (13F)
Name | % Change |
---|---|
ALPN Alpine Immune Scienc | 1.63% |
ADVM Avalanche Biotechnol | 1.59% |
CRNX Crinetics Pharmaceut | 1.29% |
GTH Genetron Holdings Lt | 0.86% |
SVRA Savara Inc | 0.82% |
2024-06-30
13F Holdings Summary
Name | $ Change |
---|---|
SLNO Soleno Therapeutics | 27.58% |
GERN Geron Corp | 10.66% |
HRMY Harmony Biosciences | 7.26% |
SVA Sinovac Biotech Ltd | 7.05% |
DYN Dyne Therapeutics, I | 5.33% |
2024-06-30
13F Activity
Market Value | $1.08b, Prior: $1.27b |
Inflows (Outflows) as % of Total MV | (-5.6763)% |
New Purchases | 4 stocks |
Added To | 2 stocks |
Sold out of | 4 stocks |
Reduced holdings in | 6 stocks |
Top 10 Holdings % | 76.04% |
Turnover %[1] | 17.39% |
Turnover Alt %[2] | 4.09% |
Time Held Top 20 | 5.4 quarters |
Time Held Top 10 | 4.7 quarters |
Time Held All | 10.24 quarters |
[1]: Turnover is calculated by taking the # of new holdings (initial purchases) + the # of positions sold out of (not just reduced) divided by the total # of holdings for the quarter.
[2]: Alt Turnover is calculated by taking either the total MV of new purchases or the MV of securities sold, whichever is less, divided by the total MV of the fund.
2024-06-30
13F Sector Allocation Over Time
limited to past 4 quarters. Subscribe to see all available data
2024-06-30
Analysis
Top 20 equal-weighted holdings. Performance numbers calculated through 2024-06-30